Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06708143

Temporal Interference for Drug Resistant Epilepsy

Noninvasive Temporal Interference Stimulation for the Treatment of Drug Resistant Epilepsy

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Xuanwu Hospital, Beijing · Academic / Other
Sex
All
Age
6 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This single-center prospective study aims to investigate the treatment efficacy of temporal interference (TI) in drug-resistant epilepsy patients aged 6-60.

Detailed description

Temporal Interference (TI) technology is a novel non-invasive method for deep brain stimulation (DBS). By generating an overlapping electric field from safe currents, TI creates focused stimulation in targeted deep brain areas. This approach allows for the exploration of deep brain nuclei functions and has the potential to serve as a non-invasive alternative to traditional invasive DBS for clinical treatments. This study aims to investigate the treatment efficacy of TI deep brain stimulation by including drug-resistant patients aged 6-60. During and after TI stimulation, clinical and electrophysiology data will be recorded. Clinical, imaging and electrophysiology data will be analyzed and processed to advance the treatment of drug-resistant epilepsy.

Conditions

Interventions

TypeNameDescription
OTHERTemporal InterferenceResearchers apply temporal interference (TI) stimulation to the deep brain nuclei of drug resistant epilepsy patients.

Timeline

Start date
2024-11-30
Primary completion
2028-11-30
Completion
2028-11-30
First posted
2024-11-27
Last updated
2024-11-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06708143. Inclusion in this directory is not an endorsement.